Dermatological Therapeutics Market
Global Dermatological Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-infectives, Corticosteroids, Calcineurin Inhibitors, Retinoids, and Others), By Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Metastatic Malignant Melanoma, and Others), and Forecast 2019-2025 Update Available - Forecast 2024-2030
The global dermatological therapeutics market is estimated to grow significantly during the forecast period. Rapid urbanization and increasing disposable income have increased care and concern regarding skin among others which is leading to considerable growth of the global dermatological therapeutics market. The primary factors that drive the growth of the market include the increased cases of skin-related disorders, such as, metastatic malignant melanoma, alopecia, herpes, and psoriasis, among others. Thus, the need for the treatment of such diseases at the earliest possible stage has further fueled the development of sophisticated and advanced therapeutics in the market, which,in turn, has increased competition among manufacturers and aided significantly to the growth of the global market during the forecast period.
Additionally, the rising expenditure on healthcare and enhanced health insurance coverage. However, higher costs associated with the R&D and development of the drug along with the increasing cost of therapy are some of the factors that are projected to hinder the growth of the global dermatological therapeutics market. Besides, continuous contributions by the key players along with several government policies and awareness programs are likely to create scope for the market growth. Further, conferences such as World Dermatology Congress, World Dermatology and Aesthetic Congress, International Dermatology Conference, and many others are held across the globe, which is likely to create awareness as well as scope for the market growth.
Segmental Outlook
The global dermatological therapeutics market is segmented on the basis of drug class and application. Based on the drug class, the market is segmented into anti-infectives, corticosteroids, calcineurin inhibitors, retinoids, and others. Based on the application, the market is segmented into alopecia, herpes, psoriasis, rosacea, atopic dermatitis, metastatic malignant melanoma, and others.
Metastatic Malignant Melanoma to Contribute a Significant Share in the Market
Amongst the applications of the global dermatological therapeutics market, metastatic malignant melanoma is likely to contribute a significant share in the market during the forecast period. The segmental growth is attributed to the rising incidences of melanoma cases across the globe. As per the World Cancer Research Fund International, melanoma is among the top 20 most common cancer amongst the peoples. In 2018, there were around 300,000 new cases globally. Whereas, in 2018, non-melanoma skin cancer is the 5th commonly occurring cancer, with more than 1 million cases globally. Thus, this is expected to enhance the demand for the dermatological therapeutics industry globally.
Regional Outlook
The global dermatological therapeutics market is geographically segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Europe is expected to contribute a significant share in the global market during the forecast period. The regional growth is attributed to the developed economies in the region, which offers a significant infrastructure to provide modern technologies related to dermatological products and related drugs to its citizen. High per capita disposable income in the region and the high proportion of the middle-aged population in the region is also the major factors for the growth of the market. As per the United Nations, around 45% of the total population in Europe is in the age range of 35-64 years in 2019, which is the highest end-user for the market during the forecast period.
Global Dermatological Therapeutics Market, by Region 2018 (%)
Market Players Outlook
Numerous major players are operating in the global dermatological therapeutics industry and providing various drugs for skin treatment. Some of the prominent players operating in the market include AbbVie Inc., Allergan PLC., Amgen Inc., Johnson & Johnson Services Inc., Novartis International AG, Eli Lilly & Co., and LEO Pharma A/S. These are the key companies adopting several organic and inorganic growth strategies such as product launches & developments, partnerships, agreements, and acquisitions to strengthen their product portfolios and maintain a competitive position in the global dermatological therapeutics market.
For instance, in January 2020, Eli Lilly & Co. announced its plans to buy medical dermatology company Dermira Inc. The Menlo Park business that Lilly is acquiring focuses on the treatment of common skin conditions. One product in its pipeline is an eczema treatment called Lebrikizumab that was granted Fast Track designation from the US FDA in December 2019.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global dermatological therapeutics market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Amgen Inc.
3.2.1.1. Overview
3.2.1.2. Financial Analysis
3.2.1.3. SWOT Analysis
3.2.1.4. Recent Developments
3.2.2. Novartis International AG
3.2.2.1. Overview
3.2.2.2. Financial Analysis
3.2.2.3. SWOT Analysis
3.2.2.4. Recent Developments
3.2.3. Abbvie Inc.
3.2.3.1. Overview
3.2.3.2. Financial Analysis
3.2.3.3. SWOT Analysis
3.2.3.4. Recent Developments
3.2.4. Allergan PLC
3.2.4.1. Overview
3.2.4.2. Financial Analysis
3.2.4.3. SWOT Analysis
3.2.4.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Dermatological Therapeutics Market by Drug Class
5.1.1. Anti-infectives
5.1.2. Corticosteroids
5.1.3. Calcineurin Inhibitors
5.1.4. Retinoids
5.1.5. Others
5.2. Global Dermatological Therapeutics Market by Application
5.2.1. Alopecia
5.2.2. Herpes
5.2.3. Psoriasis
5.2.4. Rosacea
5.2.5. Atopic Dermatitis
5.2.6. Metastatic Malignant Melanoma
5.2.7. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Aclaris Therapeutics, Inc.
7.3. Allergan PLC
7.4. Almirall SA
7.5. Amgen Inc.
7.6. Aurobindo Pharma Ltd.
7.7. Bausch Health Companies Inc.
7.8. Cipher Pharmaceuticals Inc.
7.9. Eli Lilly & Co.
7.10. Galderma SA
7.11. GlaxoSmithKline PLC
7.12. Glenmark Pharmaceuticals Ltd.
7.13. Johnson & Johnson Services Inc.
7.14. LEO Pharma A/S
7.15. Novartis International AG
7.16. Pfizer Inc.
7.17. Sanofi SA
7.18. Sun Pharmaceutical Industries Ltd.
1. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
2. GLOBAL ANTI-INFECTIVES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL CALCINEURIN INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL RETINOIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL OTHER DERMATOLOGICAL THERAPEUTICS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
8. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR ALOPECIA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR HERPES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR PSORIASIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR ROSACEA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR A TOPIC DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR METASTATIC MALIGNANT MELANOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
14. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
16. NORTH AMERICAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
17. NORTH AMERICAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
18. NORTH AMERICAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
19. EUROPEAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
20. EUROPEAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
21. EUROPEAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
22. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
23. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
24. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
25. REST OF THE WORLD DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
26. REST OF THE WORLD DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SHARE BY DRUG CLASS, 2018 VS 2025 (%)
2. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. US DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
5. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
6. UK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
7. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
8. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
9. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
10. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
11. ROE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
12. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
13. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
14. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF THE WORLD DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
